Coherus Oncology Inc (CHRS)

CapEx to Revenue

0.00%

Quarterly · Period ending:

CHRS logo

CHRS CapEx to Revenue

Latest reported0.00%
CHRS Quarterly CapEx/Revenue (33.20% → 0.00%)
High-resolution chart · PNG

CHRS capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Coherus Oncology Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.0371%
0%
0.1703%
0.4686%
0.1918%
1.0061%
1.463%
1.023%
0.6379%
0.3164%
0.4735%
0.1746%
0.8622%
1.86%
1.7572%
1.5347%
0.3125%
0.822%
0.2181%
0.903%
0%
0%
0%
0%
0%
0%
68.8889%
1,050.3106%
422.5118%
0.3071%
2.1396%
17.38%
14.1596%
33.4729%
14.681%
22.599%
7.5312%
5.0274%
26.0423%
7.2303%
12.013%
10.4743%
0.789%
33.2016%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.